These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 288932)

  • 1. Organ-selective action of an antitumor drug: pharmacologic studies of liposome-encapsulated beta-cytosine arabinoside administered via the respiratory system of the rat.
    McCullough HN; Juliano RL
    J Natl Cancer Inst; 1979 Sep; 63(3):727-31. PubMed ID: 288932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled delivery of an antitumor drug: localized action of liposome encapsulated cytosine arabinoside administered via the respiratory system.
    Juliano RL; McCullough HN
    J Pharmacol Exp Ther; 1980 Aug; 214(2):381-7. PubMed ID: 7391983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats.
    Parker RJ; Priester ER; Sieber SM
    Drug Metab Dispos; 1982; 10(1):40-6. PubMed ID: 6124381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
    Rubas W; Supersaxo A; Weder HG; Hartmann HR; Hengartner H; Schott H; Schwendener R
    Int J Cancer; 1986 Jan; 37(1):149-54. PubMed ID: 3941019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and metabolism of lipsome-encapsulated and free 1-beta-D-arabinofuranosylcytosine (Ara-C) in dog and mouse tissues.
    Ellens H; Rustum Y; Mayhew E; Ledesma E
    J Pharmacol Exp Ther; 1982 Aug; 222(2):324-30. PubMed ID: 7097552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.
    Rahman YE; Patel KR; Cerny EA; Maccoss M
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1105-12. PubMed ID: 6540691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin.
    Juliano RL; Stamp D
    Biochem Pharmacol; 1978 Jan; 27(1):21-7. PubMed ID: 619903
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of intravenously implanted Lewis lung carcinoma with liposome-encapsulated cytosine arabinoside and non-specific immunotherapy.
    Patel KR; Baldeschwieler JD
    Int J Cancer; 1984 Sep; 34(3):415-20. PubMed ID: 6384069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of prolonged-release derivative of cytosine arabinoside, cytosine arabinoside-agarose conjugate.
    Hashida M; Kojima T; Muranishi S; Sezaki H
    Gan; 1978 Dec; 69(6):839-43. PubMed ID: 750275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of anti-tumor activity of 1-beta-D-arabinofuranosylcytosine by encapsulation in liposomes.
    Kobayashi T; Kataoka T; Tsukagoshi S; Sakurai Y
    Int J Cancer; 1977 Oct; 20(4):581-7. PubMed ID: 914397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size.
    Hunt CA; Rustum YM; Mayhew E; Papahadjopoulos D
    Drug Metab Dispos; 1979; 7(3):124-8. PubMed ID: 38080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.
    Ganapathi R; Krishan A; Wodinsky I; Zubrod CG; Lesko LJ
    Cancer Res; 1980 Mar; 40(3):630-3. PubMed ID: 7471083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of chemotherapeutic effect by entrapping 1-beta-D-arabinofuranosylcytosine in lipid vesicles and its mode of action.
    Kataoka T; Kobayashi T
    Ann N Y Acad Sci; 1978; 308():387-94. PubMed ID: 279298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of delivery of liposome-encapsulated cytosine arabinoside to CV-1 cells in vitro. Fluorescence-microscopic and cytotoxicity studies.
    Brown PM; Silvius JR
    Biochim Biophys Acta; 1990 Apr; 1023(3):341-51. PubMed ID: 2110480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Danhauser LL; Rustum YM
    Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.
    Jaafar-Maalej C; Diab R; Andrieu V; Elaissari A; Fessi H
    J Liposome Res; 2010 Sep; 20(3):228-43. PubMed ID: 19899957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of central nervous system leukemia in mice by liposome-entrapped 1-beta-D-arabinofuranosylcytosine.
    Hong F; Mayhew E
    Cancer Res; 1989 Sep; 49(18):5097-102. PubMed ID: 2766280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vesicle size on the clearance, distribution, and tumor uptake of temperature-sensitive liposomes.
    Magin RL; Hunter JM; Niesman MR; Bark GA
    Cancer Drug Deliv; 1986; 3(4):223-37. PubMed ID: 3567843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.
    Allen TM; Mehra T; Hansen C; Chin YC
    Cancer Res; 1992 May; 52(9):2431-9. PubMed ID: 1568213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD; Chen SR; Cuddy DP
    Cancer Res; 1990 May; 50(9):2658-66. PubMed ID: 2328491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.